What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report - Archive ouverte HAL Access content directly
Journal Articles International Journal of Environmental Research and Public Health Year : 2021

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report

Abstract

Background: Opioid use disorder (OUD) is a complex condition that can require long-term treatment. Pharmacological therapy for OUD involves treatment with opioid agonists (OMT) tailored to individual profiles. The aim of our study in daily clinical practice was to compare the profiles of patients treated with methadone (MTD) and those using buprenorphine (BHD or BHD-naloxone-NX). Methods: A cross-sectional multicentre study explored the psychological, somatic and social profiles of patients with Opioid Use Disorder (OUD) following Opioid Maintenance Treatment (BHD, BHD/NX, or MTD). Descriptive and comparative analyses were performed Results: 257 patients were included, a majority were men using heroin. 68% (178) were on MTD, 32% (79) were on BHD. Patients with MTD were significantly more likely to report socio-affective damage, and more likely to be younger and not to report oral or sublingual use as the main route for heroin or non-medical opioids Conclusions: In daily clinical practice, regarding OUD damage, only socio-affective damage was significantly more prevalent among patients on MTD than among those on BHD in the multivariate model. Age and route of administration also differed, and our results could raise the issue of the type of OMT prescribed in case of non-medical use of prescribed opioids. These hypothesis should be confirmed in larger studies
Fichier principal
Vignette du fichier
Guillou-Landreat_2021_What Differs between.pdf (318.51 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03211107 , version 1 (28-04-2021)

Identifiers

Cite

Morgane Guillou-Landréat, Antoine Dany, Gaëlle Challet-Bouju, Edouard Laforgue, Juliette Leboucher, et al.. What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩. ⟨hal-03211107⟩
59 View
68 Download

Altmetric

Share

Gmail Facebook X LinkedIn More